Lenalidomide plus dexamethasone for patients with relapsed or refractory multiple myeloma: Final results of a non-interventional study and comparison with the pivotal phase 3 clinical trials.

Knauf, W., Aldaoud, A., Losem, C., Mittermueller, J., Neise, M., Niemeier, B., Harde, J., Trarbach, T., Potthoff, K., 2018.

Leuk. Res. 68, 90–97. doi:10.1016/j.leukres.2018.03.008